Scientists use nanoparticles to improve chemotherapy response, boost anti-tumor immunity

Scientists at the University of Toronto's Leslie Dan Faculty of Pharmacy have seen remarkable success combining tumor modulating nanoparticles with doxorubicin to enhance chemotherapy response in pre-clinical model breast cancer. This combination approach also appears to boost anti-tumor immunity, contributing to the growing excitement surrounding immunotherapy as an avenue to treat cancer.